article thumbnail

The rise of prescription drug abuse and drug diversion

pharmaphorum

As prescription drug abuse has grown in the US and Europe, the diversion of such treatments from legitimate sources has also increased. Drug diversion is the channelling of prescription drugs from a medical source into the illegal market. The post The rise of prescription drug abuse and drug diversion appeared first on.

article thumbnail

Why we need to support healthcare’s vital acceleration

pharmaphorum

Mergers and acquisitions are contributing to consolidation, with about 2,600 healthcare deals globally in 2022, up from 1,500 in 2016. Attracted by healthcare’s steady and rising revenues, financial investors made 55% of 2022’s acquisitions, up from 43% in 2016.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

4 Ways to Meet the Needs of an Increasing Health-conscious Audience

PM360

Consider the SmartLabel Digital Transparency Initiative, which was created by the Grocery Manufacturers Association and the Food Industry Association under the manufacturing companies’ and retailers’ parity-based entity called the Trading Partner Alliance in 2016. Prescription refills can now be placed with a simple click on a patient portal.

Retail 97
article thumbnail

Veradigm® Digital Health Media Works to Message the Right Physicians at the Right Time

PM360

Though 80% of healthcare providers (HCPs) identified as “rep-accessible” in 2008 (that is, willing to meet with over 70% of the sales reps who try to approach them), that number had decreased to 44% in 2017. This report compiled data from 10 studies, published from 2016 to 2021, to show that physicians spend an average of 4.5

article thumbnail

Digital Self-Neuromodulation Therapy for PTSD: Interview with Oded Kraft, CEO of GrayMatters Health

Medgadget

Hendler in 2016 and we were fascinated with both her, the technology, and the paradigm shift we can drive with her in psychiatry. Throughout 2016 and until mid-2019 we conducted a deep technology due diligence, as well as market research, and met and spoke with dozens of mental healthcare providers.